Literature DB >> 10728713

Overexpression of PTEN/MMAC1 and decreased activation of Akt in human papillomavirus-infected laryngeal papillomas.

P Zhang1, B M Steinberg.   

Abstract

Laryngeal papillomas are benign, human papillomavirus-induced hyperplastic tumors of the respiratory tract. They are characterized by overexpression of the epidermal growth factor receptor, constitutive activation of mitogen-activated protein kinase, a low proliferative rate, and defects in differentiation. We have now found that phosphoinositol 3-kinase (PI 3-K) activity is significantly increased in papilloma tissue. However, phosphorylated Akt (also known as protein kinase B), a downstream effector of PI 3-K, is reduced when compared with normal tissue. The ratio of activated Akt to total Akt is much lower in papillomas than in normal laryngeal tissue, suggesting decreased Akt activation. PTEN/ MMAC1 is a tumor suppressor that dephosphorylates phosphatidylinositol 3,4,5-triphosphate, an intermediate in the PI 3-K/Akt signaling pathway. We have found that PTEN protein is overexpressed in laryngeal papillomas when compared with normal laryngeal tissues. On the basis of reverse transcription-PCR analysis, PTEN mRNA is more abundant in papillomas, suggesting transcriptional up-regulation. We postulate that negative regulation of the PI 3-K/Akt pathway by PTEN may modulate the effects of the hyperactive epidermal growth factor receptor/mitogen-activated protein kinase pathway, contributing to the low proliferation and dysfunctional differentiation of laryngeal papillomas.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10728713

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  Reduction of p38 mitogen-activated protein kinase and cyclooxygenase-2 signaling by isoflurane inhibits proliferation and apoptosis evasion in human papillomavirus-infected laryngeal papillomas.

Authors:  Hongbo Ren; Xiaojuan Shi; Ying Li
Journal:  Exp Ther Med       Date:  2016-10-04       Impact factor: 2.447

2.  Role of phosphoinositide 3-kinase in the aggressive tumor growth of HT1080 human fibrosarcoma cells.

Authors:  S Gupta; S Stuffrein; R Plattner; M Tencati; C Gray; Y E Whang; E J Stanbridge
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

3.  Phosphatidylinositol 3-kinase regulates early differentiation in human laryngeal keratinocytes.

Authors:  Raduwan Dackour; Timothy Carter; Bettie M Steinberg
Journal:  In Vitro Cell Dev Biol Anim       Date:  2005 Mar-Apr       Impact factor: 2.416

4.  Increased p50/p50 NF-kappaB activation in human papillomavirus type 6- or type 11-induced laryngeal papilloma tissue.

Authors:  Ivana Vancurova; Rong Wu; Veronika Miskolci; Shishinn Sun
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

5.  Pak1 and Pak2 are activated in recurrent respiratory papillomas, contributing to one pathway of Rac1-mediated COX-2 expression.

Authors:  Rong Wu; Allan L Abramson; Marc H Symons; Bettie M Steinberg
Journal:  Int J Cancer       Date:  2010-11-01       Impact factor: 7.396

6.  Requirement of STAT3 activation for differentiation of mucosal stratified squamous epithelium.

Authors:  Rong Wu; Shishinn Sun; Bettie M Steinberg
Journal:  Mol Med       Date:  2003 Mar-Apr       Impact factor: 6.354

7.  Up-regulation of Rac1 by epidermal growth factor mediates COX-2 expression in recurrent respiratory papillomas.

Authors:  Rong Wu; Salvatore J Coniglio; Amanda Chan; Marc H Symons; Bettie M Steinberg
Journal:  Mol Med       Date:  2007 Mar-Apr       Impact factor: 6.354

8.  Immune dysregulation and tumor-associated gene changes in recurrent respiratory papillomatosis: a paired microarray analysis.

Authors:  James A DeVoti; David W Rosenthal; Rong Wu; Allan L Abramson; Bettie M Steinberg; Vincent R Bonagura
Journal:  Mol Med       Date:  2008 Sep-Oct       Impact factor: 6.354

Review 9.  The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses.

Authors:  Lifang Zhang; Jianhong Wu; Ming Tat Ling; Liang Zhao; Kong-Nan Zhao
Journal:  Mol Cancer       Date:  2015-04-17       Impact factor: 27.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.